ReviewFrontiers in pharmacology2026
Molecular mechanisms and therapeutic potential of natural products and traditional Chinese medicine formulas in ADHD: a review of preclinical evidence.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition marked by inattention, hyperactivity, and impulsivity. Although current pharmacotherapies are effective for many patients, their clinical utility is frequently limited by insufficient efficacy, adverse effects, and concerns regarding long-term tolerability or patient acceptance. Accordingly, increasing research attention has been directed toward the therapeutic potential of traditional Chinese medicine (TCM) formulas and other natural products, which are thought to offer multi-target mechanisms and holistic regulatory effects. This review provides a critical synthesis of recent preclinical studies, focusing on the molecular mechanisms by which specific TCM formulas and natural products ameliorate ADHD-like behaviors. We delineate these actions across several biological scales, including the modulation of catecholamine neurotransmission, enhancement of neurodevelopment and synaptic plasticity, attenuation of neuroinflammation, and regulation of the gut-brain axis. In addition, this review highlights current limitations, including the overreliance on single animal models and the insufficient integration of pharmacokinetic and translational data. Finally, we discuss future research directions and aim to provide new perspectives for the development of natural product-derived interventions in ADHD management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.